Enfortumab Vedotin (EV) with Pembrolizumab (P) Versus Chemotherapy (chemo) in Previously Untreated Locally Advanced or Metastatic Urothelial Carcinoma (la/muc): Analysis of Cisplatin (Cis)-Eligible Population from EV-302/KEYNOTE-A39
JOURNAL OF CLINICAL ONCOLOGY(2024)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined